Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jun 19, 2025
Open Peer Review Period: Jun 24, 2025 - Aug 19, 2025
Date Accepted: Jan 15, 2026
Date Submitted to PubMed: Jan 19, 2026
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Efficacy of Tuina for Myopia in children: A protocol for a randomized controlled trail
ABSTRACT
Background:
Myopia has emerged as a major threat to the visual health of adolescents worldwide. Early intervention can effectively slow down the progression of myopia in adolescents. Tuina, a significant therapeutic method in traditional Chinese medicine, has shown promising clinical efficacy in delaying the progression of myopia; however, it lacks robust, large-scale, and standardized randomized controlled trials.
Objective:
This study aims to explore the efficacy and safety of Tuina therapy in managing myopia in adolescents, thereby providing solid evidence for the application of Tuina in the clinical treatment of myopia.
Methods:
The design of this study is a multicenter, single-blind, randomized controlled clinical trial. We will include 192 myopic children from four hospitals, who will be randomly assigned in a 1:1 ratio to a Tuina experimental group and a drug-positive control group (tropicamide eye drops). Treatments in each group will be three times a week, for a total of 8 weeks. The Tuina therapy experimental group will receive 20 minutes of Tuina therapy per session, while the drug-positive control group will use tropicamide eye drops, administered every other day, with two drops per session. The primary outcome measures include uncorrected visual acuity and axial length, with secondary measures including refractive power and accommodative amplitude. Data will be collected on the day of enrollment and treatment (week 0), on the day of completion of the 4th and 8th weeks of treatment, and at the end of the 10-week follow-up. Adverse events will be monitored and recorded throughout the study, and statisticians will be blinded. Data will be analyzed using SPSS 28.0.
Results:
This study has been funded, and data collection is expected to take place between June 2026 and June 2026. Final manuscript submission should happen by August 2026.
Conclusions:
This study aims to evaluate the efficacy and safety of massage therapy in the treatment of myopic adolescents. We hypothesize that the therapeutic effect of massage therapy is non-inferior to that of topical atropine eye drops, with the added advantages of fewer side effects and stable long-term efficacy, thereby providing reliable evidence and support for the application of massage therapy in the management of myopia in adolescents.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.